Basit öğe kaydını göster

dc.contributor.authorBosnak-Guclu, Meral
dc.contributor.authorArikan, Hulya
dc.contributor.authorSavci, Sema
dc.contributor.authorInal-Ince, Deniz
dc.contributor.authorTulumen, Erol
dc.contributor.authorAytemir, Kudret
dc.contributor.authorTokgozoglu, Lale
dc.date.accessioned2019-12-19T06:46:11Z
dc.date.available2019-12-19T06:46:11Z
dc.date.issued2011
dc.identifier.issn0954-6111
dc.identifier.urihttps://doi.org/10.1016/j.rmed.2011.05.001
dc.identifier.urihttp://hdl.handle.net/11655/20813
dc.description.abstractAim: To investigate the effects of inspiratory muscle training (IMT) on functional capacity and balance, respiratory and peripheral muscle strength, pulmonary function, dyspnea, fatigue, depression, and quality of life in heart failure patients. Methods: A prospective, randomized controlled, double-blinded study. Thirty patients with heart failure (NYHA II-III, LVEF<40%) were included. Sixteen patients received IMT at 40% of maximal inspiratory pressure (MIP), and 14 patients received sham therapy (15% of MIP) for 6 weeks. Functional capacity and balance, respiratory muscle strength, quadriceps femoris muscle strength, pulmonary function, dyspnea, fatigue, quality of life, and depression were evaluated. Results: Functional capacity and balance, respiratory and peripheral muscle strength, dyspnea, depression were significantly improved in the treatment group compared with controls; quality of life and fatigue were similarly improved within groups (p < 0.05). Functional capacity (418.59 +/- 123.32 to 478.56 +/- 131.58 m, p < 0.001), respiratory (MIP = 62.00 +/- 33.57 to 97.13 +/- 32.63 cmH(2)O, p < 0.001) and quadriceps femoris muscle strength (240.91 +/- 106.08 to 301.82 +/- 111.86 N, p < 0.001), FEV1%, FVC% and PEF%, functional balance (52.73 +/- 3.15 to 54.25 +/- 2.34, p < 0.001), functional dyspnea (2.27 +/- 0.88 to 1.07 +/- 0.79, p < 0.001), depression (11.47 +/- 7.50 to 3.20 +/- 4.09, p < 0.001), quality of life, fatigue (42.73 +/- 11.75 to 29.07 +/- 13.96, p < 0.001) were significantly improved in the treatment group. Respiratory muscle strength (MIP = 78.64 +/- 35.95 to 90.86 +/- 30.23 cmH(2)O, p = 0.001), FVC%, depression (14.36 +/- 9.04 to 9.50 +/- 10.42, p = 0.011), quality of life and fatigue (42.86 +/- 12.67 to 32.93 +/- 15.87, p = 0.008) were significantly improved in the control group. Conclusion: The IMT improves functional capacity and balance, respiratory and peripheral muscle strength; decreases depression and dyspnea perception in patients with heart failure. IMT should be included effectively in pulmonary rehabilitation programs. (C) 2011 Elsevier Ltd. All rights reserved.
dc.language.isoen
dc.publisherW B Saunders Co Ltd
dc.relation.isversionof10.1016/j.rmed.2011.05.001
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCardiovascular System & Cardiology
dc.subjectRespiratory System
dc.titleEffects Of Inspiratory Muscle Training In Patients With Heart Failure
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalRespiratory Medicine
dc.contributor.departmentErgoterapi
dc.identifier.volume105
dc.identifier.issue11
dc.identifier.startpage1671
dc.identifier.endpage1681
dc.description.indexWoS
dc.description.indexScopus


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster